Impact of vaccination on ICU admissions of hospitalized COVID-19 patients in a country with a heterologous vaccine policy

Authors

  • Süleyman Yıldırım University of Health Sciences Turkey, Izmir School of Medicine, Dr. Suat Seren Chest Disease and Surgery Training and Research Hospital, Intensive Care Unit, Izmir, Turkey https://orcid.org/0000-0001-9856-3431
  • Cenk Kirakli University of Health Sciences Turkey, Izmir School of Medicine, Dr. Suat Seren Chest Disease and Surgery Training and Research Hospital, Intensive Care Unit, Izmir, Turkey
  • Yeliz Özdemir University of Health Sciences Turkey, Izmir School of Medicine, Bozyaka Training and Research Hospital, Department of Infectious Disease and Clinical Microbiology, Izmir, Turkey
  • Selma Tosun University of Health Sciences Turkey, Izmir School of Medicine, Bozyaka Training and Research Hospital, Department of Infectious Disease and Clinical Microbiology, Izmir, Turkey https://orcid.org/0000-0001-9844-9399
  • Sinem Ermin University of Health Sciences Turkey, Izmir School of Medicine, Dr. Suat Seren Chest Disease and Surgery Training and Research Hospital, Department of Pulmonology, Izmir, Turkey https://orcid.org/0000-0002-0400-9403
  • Gülru Polat University of Health Sciences Turkey, Izmir School of Medicine, Dr. Suat Seren Chest Disease and Surgery Training and Research Hospital, Department of Pulmonology, Izmir, Turkey
  • Celalettin Yılmaz University of Health Sciences Turkey, Izmir School of Medicine, Dr. Suat Seren Chest Disease and Surgery Training and Research Hospital, Department of Pulmonology, Izmir, Turkey
  • Semra Bilaçeroğlu University of Health Sciences Turkey, Izmir School of Medicine, Dr. Suat Seren Chest Disease and Surgery Training and Research Hospital, Department of Pulmonology, Izmir, Turkey https://orcid.org/0000-0002-9703-9598
  • Bilge Salık University of Health Sciences Turkey, Izmir School of Medicine, Dr. Suat Seren Chest Disease and Surgery Training and Research Hospital, Department of Pulmonology, Izmir, Turkey
  • Berna Kömürcüoğlu University of Health Sciences Turkey, Izmir School of Medicine, Dr. Suat Seren Chest Disease and Surgery Training and Research Hospital, Department of Pulmonology, Izmir, Turkey
  • İlker Ödemiş University of Health Sciences Turkey, Izmir Faculty of Medicine, Izmir Tepecik Training and Research Hospital, Department of Infectious Disease and Clinical Microbiology, Izmir, Turkey https://orcid.org/0000-0003-2638-0163
  • Şükran Köse University of Health Sciences Turkey, Izmir Faculty of Medicine, Izmir Tepecik Training and Research Hospital, Department of Infectious Disease and Clinical Microbiology, Izmir, Turkey
  • Uğur Uzun University of Health Sciences Turkey, Izmir Faculty of Medicine, Izmir Tepecik Training and Research Hospital, Department of Anesthesiology and Reanimation, Izmir, Turkey
  • Gaye Aydın University of Health Sciences Turkey, Izmir Faculty of Medicine, Izmir Tepecik Training and Research Hospital, Department of Anesthesiology and Reanimation, Izmir, Turkey
  • Enver İlhan University of Health Sciences Turkey, Izmir Faculty of Medicine, Bozyaka Research and Training Hospital, Izmir, Turkey

DOI:

https://doi.org/10.3855/jidc.18342

Keywords:

COVID-19, vaccination, hospitalization, intensive care unit

Abstract

Introduction: Vaccination against coronavirus disease-19 (COVID-19) is highly effective in preventing severe disease and mortality. Adenoviral vector and mRNA vaccines were effective against intensive care unit (ICU) admission, but the effectiveness of inactivated vaccine on ICU admission was unclear. We aimed to evaluate the effect of vaccination status on ICU admission in hospitalized COVID-19 patients in a country with heterologous vaccination policy.

Methodology: This is a retrospective multicenter study conducted in three hospitals in Izmir, Turkey between 1 January 2021 and 31 March 2022. Patients aged ≥ 18 years and hospitalized due to COVID-19 were included in the study. Patients who had never been vaccinated and patients who had been vaccinated with a single dose were considered unvaccinated. A logistic regression analysis was performed for evaluating risk factors for ICU admission.

Results: A total of 2,110 patients were included in the final analysis. The median age was 66 years (IQR, 53-76 years) and 54% of the patients were vaccinated. During the study period, 407 patients (19.3%) were transferred to the ICU due to disease severity. Patients who were admitted to the ICU were older (median age 68 vs. 65 years, p < 0.001); and the number of unvaccinated individuals was higher among ICU patients (57% vs. 45%, p < 0.001). In multivariate regression analysis, being unvaccinated was found to be the most important independent risk factor for ICU admission with an OR of 2.06 (95% CI, 1.64-2.59).

Conclusions: Vaccination against COVID-19 is effective against ICU admission and hospital mortality.

Downloads

Published

2024-04-30

How to Cite

1.
Yıldırım S, Kirakli C, Özdemir Y, Tosun S, Ermin S, Polat G, Yılmaz C, Bilaçeroğlu S, Salık B, Kömürcüoğlu B, Ödemiş İlker, Köse Şükran, Uzun U, Aydın G, İlhan E (2024) Impact of vaccination on ICU admissions of hospitalized COVID-19 patients in a country with a heterologous vaccine policy. J Infect Dev Ctries 18:513–519. doi: 10.3855/jidc.18342

Issue

Section

Coronavirus Pandemic